InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Cost and duration of patent litigation


With more patents issuing than ever before, there is a greater likelihood that your company will become a party to patent litigation. It is important, therefore, to familiarise yourself with the basic factors affecting the cost and duration of patent litigation.

The average patent litigation lasts about two years and costs about $3 million. An appeal can add another $2 million and one year to that estimate.

Patent litigation cost and duration depend on a variety of factors. Our firm represented a generic pharmaceutical company in litigation involving a product with over $1...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @OAMITWEETS: Our webinar programme for July 7 http://t.co/CbPXRi0ITB

Jul 3 2015 11:45 ·  reply ·  retweet ·  favourite
ManagingIP profile

Zound takes on Lidl over Urbanears Plattan headphones using German Unf. Comp. law ($/trial) http://t.co/iHbuX0Fgn8 http://t.co/elGCjIFcuB

Jul 3 2015 11:44 ·  reply ·  retweet ·  favourite
ManagingIP profile

David Knight of @Fieldfisher discussing the Big Bus patent licence case (he's on the right) http://t.co/XqcyJBPR6W http://t.co/38Mc7eXLf5

Jul 2 2015 04:25 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


INTA Daily News 2015

Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in San Diego


June 2015

The fine line between abuse and fair use at the PTAB

Hedge fund manager Kyle Bass has outraged the pharma and biotech industries by seeking to invalidate their patents at the PTAB, with some observers linking his attacks to short-selling of company stocks. Michael Loney reports on a controversy that goes to the heart of the US patent system



Most read articles

Supplements